Safety and clinical activity of pembrolizumab for treatmentThe Lancet
www.thelancet.com
von TY Seiwert · · Zitiert von: — Christine Gause, Jonathan D Cheng, Laura Q Chow. Summary. Background Patients with recurrent or metastatic squamous cell carcinoma of the head ...
Melanoma and immunotherapy bridge 2015: Naples, Italy. ...Scholars Portal Journals
journals.scholarsportal.info
von VGY Nanda · Zitiert von: 13 — Kirkwood, Christine Gause, Lisa Chen, David R. Kaufman, Jeffrey Chou, F. Stephen Hodi. News in immunotherapy. O9 Two-year survival and safety update in ... von VGY Nanda · Zitiert von: 13 — Kirkwood, Christine Gause, Lisa Chen, David R. Kaufman, Jeffrey Chou, F. Stephen Hodi. News in immunotherapy. O9 Two-year survival and safety update in ...
Safety profile of pembrolizumab monotherapy based on an ...ScienceDirect.com
www.sciencedirect.com
von JR Brahmer · · Zitiert von: 2 — Christine Gause: Conceptualization, Data Curation, Formal Analysis, Methodology, Resources, Supervision, Writing – Review and Editing. Oswaldo L. Bracco ... von JR Brahmer · · Zitiert von: 2 — Christine Gause: Conceptualization, Data Curation, Formal Analysis, Methodology, Resources, Supervision, Writing – Review and Editing. Oswaldo L. Bracco ...
Alle Infos zum Namen "Christine Gause"
31st Annual Meeting and Associated Programs of the ...infona.pl
www.infona.pl
von A Lundqvist · · Zitiert von: 10 — Swaby, Christine Gause, Sanatan Saraf, Anthony T. C. Chan, Elaine Lam, Nizar M. Tannir, Funda Meric-Bernstam, Ulka Vaishampayan, Keith W. Orford, Chris ... von A Lundqvist · · Zitiert von: 10 — Swaby, Christine Gause, Sanatan Saraf, Anthony T. C. Chan, Elaine Lam, Nizar M. Tannir, Funda Meric-Bernstam, Ulka Vaishampayan, Keith W. Orford, Chris ...
A phase II study of combined ridaforolimus and ...National Institutes of Health (NIH) (.gov)
pubmed.ncbi.nlm.nih.gov
von J Baselga · · Zitiert von: 20 — ... Christine Gause , David Mauro , Mary Beth Jones , Hope S Rugo. Affiliations. 1 Memorial Sloan Kettering Cancer Center, New York, NY, USA. 2 H ... von J Baselga · · Zitiert von: 20 — ... Christine Gause , David Mauro , Mary Beth Jones , Hope S Rugo. Affiliations. 1 Memorial Sloan Kettering Cancer Center, New York, NY, USA. 2 H ...
A phase Ib multicohort study of MK in patients with ...ASCO Publications
ascopubs.org
von R Nanda · · Zitiert von: 17 — ... Christine Gause, Holly Brown, Jennifer Houp, Jonathan D. Cheng, and Laura Quan Man Chow Show FewerAuthors Info & Affiliations. Publication: Journal of ... von R Nanda · · Zitiert von: 17 — ... Christine Gause, Holly Brown, Jennifer Houp, Jonathan D. Cheng, and Laura Quan Man Chow Show FewerAuthors Info & Affiliations. Publication: Journal of ...
A phase Ib study of MK in patients with human ...CiNii
cir.nii.ac.jp
von TY Seiwert · · Zitiert von: 164 — Christine Gause: Merck & Co., Inc., Whitehouse Station, NJ. Robert Iannone: Merck & Co., Inc., Whitehouse Station, NJ. Holly Brown: Merck & Co., Inc., ... von TY Seiwert · · Zitiert von: 164 — Christine Gause: Merck & Co., Inc., Whitehouse Station, NJ. Robert Iannone: Merck & Co., Inc., Whitehouse Station, NJ. Holly Brown: Merck & Co., Inc., ...
Melanoma and immunotherapy bridge 2015: Naples, Italy Harvard DASH
dash.harvard.edu
von VGY Nanda · · Zitiert von: 13 — Kirkwood, Christine Gause, Lisa Chen, David R. Kaufman, Jeffrey Chou, F. Stephen Hodi News in immunotherapy O9 Two-year survival and safety update in ... von VGY Nanda · · Zitiert von: 13 — Kirkwood, Christine Gause, Lisa Chen, David R. Kaufman, Jeffrey Chou, F. Stephen Hodi News in immunotherapy O9 Two-year survival and safety update in ...
Melanoma and immunotherapy bridge 2015eScholarship
escholarship.org
von VGY Nanda · · Zitiert von: 13 — ... Christine Gause, Lisa Chen, David R. Kaufman, Jeffrey Chou, F. Stephen Hodi News in immunotherapy O9 Two-year survival and safety update in patients (pts) ... von VGY Nanda · · Zitiert von: 13 — ... Christine Gause, Lisa Chen, David R. Kaufman, Jeffrey Chou, F. Stephen Hodi News in immunotherapy O9 Two-year survival and safety update in patients (pts) ...
Safety and clinical activity of pembrolizumab for treatment ...Johns Hopkins University
pure.johnshopkins.edu
von TY Seiwert · · Zitiert von: — ... Christine Gause, Jonathan D. Cheng, Laura Q. Chow. Research output: Contribution to journal › Article › peer-review Scopus citations. von TY Seiwert · · Zitiert von: — ... Christine Gause, Jonathan D. Cheng, Laura Q. Chow. Research output: Contribution to journal › Article › peer-review Scopus citations.
Safety profile of pembrolizumab monotherapy based on an ...European Journal of Cancer
www.ejcancer.com
von JR Brahmer · · Zitiert von: 2 — ... Christine Gause u, Oswaldo L. Bracco u,. M. Catherine Pietanza u, Todd Gruber u, Antoni Ribas d a Johns Hopkins Kimmel Cancer Center, von JR Brahmer · · Zitiert von: 2 — ... Christine Gause u, Oswaldo L. Bracco u,. M. Catherine Pietanza u, Todd Gruber u, Antoni Ribas d a Johns Hopkins Kimmel Cancer Center,
A multicohort trial of the safety and efficacy of the PD ASCO Publications
ascopubs.org
von G Garcia-Manero · · Zitiert von: 4 — ... Christine Gause, Holly Brown, Ryan D. Geschwindt, Robert Iannone, Shelonitda Rose, and Phillippe Armand Show FewerAuthors Info & Affiliations. Publication ...
An International, Multicenter, Open-Label Study of ...Clinical Lymphoma, Myeloma and Leukemia
www.clinical-lymphoma-myeloma-leukemia.com
von DS Siegel · · Zitiert von: 34 — Christine Gause, Scott Vuocolo, Kenneth C. Anderson Abstract. The present study was designed to determine the efficacy and tolerability of ...
Melanoma and immunotherapy bridge TSpaceUniversity of Toronto
tspace.library.utoronto.ca
von VGY Nanda · Zitiert von: 15 — Kirkwood, Christine Gause, Lisa Chen, David R. Kaufman, Jeffrey Chou, F. Stephen Hodi News in immunotherapy O9 Two-year survival and safety ...
Verwandte Suchanfragen zu Christine Gause
Jane Wang Holly Brown Robert Iannone |
Person "Gause" (3) Vorname "Christine" (53663) Name "Gause" (158) |
sortiert nach Relevanz / Datum